SBK Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-105
Closed -$3.86K – 364
2026
Q1
$3.86K Buy
+105
New +$4.98K ﹤0.01% 243

Other funds holding NVO

SBK Financial's NVO Position: Q2 2026 in Review

SBK Financial sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 105 shares — an estimated $3.86K sold.

SBK Financial first reported a position in NVO in Q1 2026 and held it in 1 quarter. The position peaked at $3.86K in Q1 2026. 1,365 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SBK Financial reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • SBK Financial sold 105 Novo Nordisk shares in Q2 2026, an estimated $3.86K.
  • SBK Financial first reported a position in Novo Nordisk in Q1 2026 and held it in 1 quarter.
  • SBK Financial's Novo Nordisk position peaked at $3.86K in Q1 2026.
  • 1,365 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.